chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Headache, Vaccination site discolouration, Vaccination site haemorrhage, Wrong technique in product usage process
Clinical narrative: The vaccination site became black and blue; Pain under my armpit; headaches; Bled alot (almost squirting out blood from arm); Vaccinator put the bandage on first then injected patient with the needle (over the bandage); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE HAEMORRHAGE (Bled alot (almost squirting out blood from arm)), WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Vaccinator put the bandage on first then injected patient with the needle (over the bandage)), VACCINATION SITE DISCOLOURATION (The vaccination site became black and blue), AXILLARY PAIN (Pain under my armpit) and HEADACHE (headaches) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination.     The patient's past medical history included Lyme disease and Hashimoto's thyroiditis in 2014. Concurrent medical conditions included Grass allergy, Allergy to molds and Allergy to antibiotic. Concomitant products included CANNABIDIOL (CBD OIL) for Joint pain, MAGNESIUM, CALCIUM, ZINC and VITAMIN D [VITAMIN D NOS] for an unknown indication.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced VACCINATION SITE HAEMORRHAGE (Bled alot (almost squirting out blood from arm)) and WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Vaccinator put the bandage on first then injected patient with the needle (over the bandage)). On an unknown date, the patient experienced VACCINATION SITE DISCOLOURATION (The vaccination site became black and blue), AXILLARY PAIN (Pain under my armpit) and HEADACHE (headaches). At the time of the report, VACCINATION SITE HAEMORRHAGE (Bled alot (almost squirting out blood from arm)), WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Vaccinator put the bandage on first then injected patient with the needle (over the bandage)), VACCINATION SITE DISCOLOURATION (The vaccination site became black and blue), AXILLARY PAIN (Pain under my armpit) and HEADACHE (headaches) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Treatment information  provided   This case was linked to US-MODERNATX, INC.-MOD-2021-077210 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Follow-up information received on 07-May 2021: New events, medical history, concomitant medication were added and vaccine information (anatomical location) was updated.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-077210:
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain in extremity
Clinical narrative: Sore arm; Fatigue; Headache; This spontaneous case was reported by an other caregiver and describes the occurrence of PAIN IN EXTREMITY (Sore arm), FATIGUE (Fatigue) and HEADACHE (Headache) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 014B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No recorded medical history).   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and HEADACHE (Headache). 01-Apr-2021, the patient experienced FATIGUE (Fatigue). At the time of the report, PAIN IN EXTREMITY (Sore arm), FATIGUE (Fatigue) and HEADACHE (Headache) outcome was unknown.            Concomitant product use was not provided by the reporter.  Treatment for the event included acetylsalicylic acid.  The patient received both scheduled doses of mRNA-1273 prior to the event; therefore, action taken with the drug in response to the event is not applicable.   This case was linked to MOD-2021-071416, MOD-2021-070988, MOD-2021-070997, MOD-2021-072067 (Patient Link).
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Myalgia, Vomiting
Clinical narrative: diarrhea; vomiting; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHEA (diarrhea), VOMITING (vomiting) and MYALGIA (sore arm) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced DIARRHEA (diarrhea), VOMITING (vomiting) and MYALGIA (sore arm). On 16-Mar-2021, DIARRHEA (diarrhea), VOMITING (vomiting) and MYALGIA (sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant information  provided. No Treatment information  provided   This case was linked to MOD21-075780, MOD21-075706, MOD-2021-077211, US-MODERNATX, INC.-MOD-2021-076718, US-MODERNATX, INC.-MOD-2021-076812 (E2B Linked Report).; Sender's Comments:  MOD21-075780: MOD21-075706: MOD-2021-077211:second case US-MODERNATX, INC.-MOD-2021-076718:Same reporter US-MODERNATX, INC.-MOD-2021-076812:Dose 2
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site haemorrhage
Clinical narrative: her mother bled on the arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE HAEMORRHAGE (her mother bled on the arm) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE HAEMORRHAGE (her mother bled on the arm). At the time of the report, VACCINATION SITE HAEMORRHAGE (her mother bled on the arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant information  provided. No Treatment information  provided   This case was linked to US-MODERNATX, INC.-MOD-2021-077167, MOD-2021-077217 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-077167: MOD-2021-077217:2nd dose US-MODERNATX, INC.-MOD-2021-077217:1st dose
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea
Clinical narrative: Nausea; Headache; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea) and HEADACHE (Headache) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 12-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, the patient experienced NAUSEA (Nausea) and HEADACHE (Headache). On 13-Apr-2021, NAUSEA (Nausea) and HEADACHE (Headache) had resolved.            No Concomitant information  provided. No Treatment information  provided   This case was linked to MOD21-075780, MOD21-075706, MOD-2021-077197, INC.-MOD-2021-076718,-MOD-2021-076812 (E2B Linked Report).; Sender's Comments:  MOD21-075780: MOD21-075706: MOD-2021-077197:first dose
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Vaccination site pain
Clinical narrative: after the first dose she had a sore left arm at the injection site; pretty bad muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (after the first dose she had a sore left arm at the injection site) and MYALGIA (pretty bad muscle aches) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     The patient's past medical history included Birth control (Nexplanon (gets replaced every three years)) since an unknown date. Concomitant products included ETONOGESTREL (NEXPLANON) for Birth control.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (after the first dose she had a sore left arm at the injection site) and MYALGIA (pretty bad muscle aches). At the time of the report, VACCINATION SITE PAIN (after the first dose she had a sore left arm at the injection site) and MYALGIA (pretty bad muscle aches) had resolved. Not Provided          Treatment included Tylenol   This case was linked to US-MODERNATX, INC.-MOD-2021-077256 (E2B Linked Report). This case was linked to MOD-2021-077256 (Patient Link).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-077256:Dose2
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site haemorrhage, Wrong technique in product usage process
Clinical narrative: vaccinator also put the bandage on first and then injected the vaccine right through the bandage; With her second dose, her mother bled on the arm but not as much as the first dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE HAEMORRHAGE (With her second dose, her mother bled on the arm but not as much as the first dose) and WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (vaccinator also put the bandage on first and then injected the vaccine right through the bandage) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 09-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced VACCINATION SITE HAEMORRHAGE (With her second dose, her mother bled on the arm but not as much as the first dose). On an unknown date, the patient experienced WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (vaccinator also put the bandage on first and then injected the vaccine right through the bandage). At the time of the report, VACCINATION SITE HAEMORRHAGE (With her second dose, her mother bled on the arm but not as much as the first dose) and WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (vaccinator also put the bandage on first and then injected the vaccine right through the bandage) outcome was unknown. Not Provided          No Concomitant information  provided. No Treatment information  provided   This case was linked to , INC.-MOD-2021-077167, MOD-2021-077210 (E2B Linked Report).; Sender's Comments:  , INC.-MOD-2021-077167: , INC.-MOD-2021-077210:1st dose
Sex: F
Vaccine: COVID19
Symptoms: Dysphagia, Feeling abnormal, Hypersensitivity, Pharyngeal swelling, Pruritus
Clinical narrative: Swelling toward back of throat and epiglottis, really constricted, had trouble swallowing; Initially felt like someone had sand papered by tongue; By 10am, I started having an allergic reaction; Swelling toward back of throat and epiglottis, really constricted, had trouble swallowing; I also had itching on abdomen; Swelling through the body - rings wouldn't go on fingers; Had super sensitivity of tongue; This spontaneous case was reported by a consumer and describes the occurrence of DYSPHAGIA (Swelling toward back of throat and epiglottis, really constricted, had trouble swallowing), FEELING ABNORMAL (Initially felt like someone had sand papered by tongue), HYPERSENSITIVITY (By 10am, I started having an allergic reaction), PHARYNGEAL SWELLING (Swelling toward back of throat and epiglottis, really constricted, had trouble swallowing) and PRURITUS (I also had itching on abdomen) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy and Seasonal allergy. Concomitant products included ALPRAZOLAM and ESTRADIOL for an unknown indication.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSPHAGIA (Swelling toward back of throat and epiglottis, really constricted, had trouble swallowing), FEELING ABNORMAL (Initially felt like someone had sand papered by tongue), HYPERSENSITIVITY (By 10am, I started having an allergic reaction), PHARYNGEAL SWELLING (Swelling toward back of throat and epiglottis, really constricted, had trouble swallowing), PRURITUS (I also had itching on abdomen), SWELLING (Swelling through the body - rings wouldn't go on fingers) and TONGUE DISCOMFORT (Had super sensitivity of tongue). At the time of the report, DYSPHAGIA (Swelling toward back of throat and epiglottis, really constricted, had trouble swallowing), FEELING ABNORMAL (Initially felt like someone had sand papered by tongue), HYPERSENSITIVITY (By 10am, I started having an allergic reaction), PHARYNGEAL SWELLING (Swelling toward back of throat and epiglottis, really constricted, had trouble swallowing), PRURITUS (I also had itching on abdomen), SWELLING (Swelling through the body - rings wouldn't go on fingers) and TONGUE DISCOMFORT (Had super sensitivity of tongue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment included Loratadine and Tylenol
Sex: F
Vaccine: COVID19
Symptoms: Swelling, Tongue discomfort
Clinical narrative: Swelling toward back of throat and epiglottis, really constricted, had trouble swallowing; Initially felt like someone had sand papered by tongue; By 10am, I started having an allergic reaction; Swelling toward back of throat and epiglottis, really constricted, had trouble swallowing; I also had itching on abdomen; Swelling through the body - rings wouldn't go on fingers; Had super sensitivity of tongue; This spontaneous case was reported by a consumer and describes the occurrence of DYSPHAGIA (Swelling toward back of throat and epiglottis, really constricted, had trouble swallowing), FEELING ABNORMAL (Initially felt like someone had sand papered by tongue), HYPERSENSITIVITY (By 10am, I started having an allergic reaction), PHARYNGEAL SWELLING (Swelling toward back of throat and epiglottis, really constricted, had trouble swallowing) and PRURITUS (I also had itching on abdomen) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy and Seasonal allergy. Concomitant products included ALPRAZOLAM and ESTRADIOL for an unknown indication.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSPHAGIA (Swelling toward back of throat and epiglottis, really constricted, had trouble swallowing), FEELING ABNORMAL (Initially felt like someone had sand papered by tongue), HYPERSENSITIVITY (By 10am, I started having an allergic reaction), PHARYNGEAL SWELLING (Swelling toward back of throat and epiglottis, really constricted, had trouble swallowing), PRURITUS (I also had itching on abdomen), SWELLING (Swelling through the body - rings wouldn't go on fingers) and TONGUE DISCOMFORT (Had super sensitivity of tongue). At the time of the report, DYSPHAGIA (Swelling toward back of throat and epiglottis, really constricted, had trouble swallowing), FEELING ABNORMAL (Initially felt like someone had sand papered by tongue), HYPERSENSITIVITY (By 10am, I started having an allergic reaction), PHARYNGEAL SWELLING (Swelling toward back of throat and epiglottis, really constricted, had trouble swallowing), PRURITUS (I also had itching on abdomen), SWELLING (Swelling through the body - rings wouldn't go on fingers) and TONGUE DISCOMFORT (Had super sensitivity of tongue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment included Loratadine and Tylenol
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site inflammation, Injection site pruritus, Injection site swelling, Pruritus
Clinical narrative: injection site red; injection site swollen; injection site itchy; injection site inflammed; itch- spread to upper chest; This spontaneous case was reported by a patient and describes the occurrence of INJECTION SITE ERYTHEMA (injection site red), INJECTION SITE SWELLING (injection site swollen), INJECTION SITE PRURITUS (injection site itchy), INJECTION SITE INFLAMMATION (injection site inflammed) and PRURITUS (itch- spread to upper chest) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 immunization.     The patient's past medical history included No adverse event (No reported medical history). Concomitant products included MONASCUS PURPUREUS, NICOTINAMIDE, PHYTOSTEROLS NOS (RED YEAST RICE WITH PLANT STEROLS) for Cholesterol.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (injection site red), INJECTION SITE SWELLING (injection site swollen), INJECTION SITE PRURITUS (injection site itchy), INJECTION SITE INFLAMMATION (injection site inflammed) and PRURITUS (itch- spread to upper chest). In January 2021, INJECTION SITE ERYTHEMA (injection site red), INJECTION SITE SWELLING (injection site swollen), INJECTION SITE PRURITUS (injection site itchy), INJECTION SITE INFLAMMATION (injection site inflammed) and PRURITUS (itch- spread to upper chest) had resolved.            Patient treated herself with one Benadryl. The events resolved within 24-hours.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pyrexia
Clinical narrative: fatigue; chills; headache; low grade fever; This spontaneous case was reported by a patient and describes the occurrence of FATIGUE (fatigue), CHILLS (chills), HEADACHE (headache) and PYREXIA (low grade fever) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 immunization.     The patient's past medical history included No adverse event (No reported medical history). Concomitant products included MONASCUS PURPUREUS, NICOTINAMIDE, PHYTOSTEROLS NOS (RED YEAST RICE WITH PLANT STEROLS) for Cholesterol.    On 10-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021 at 9:00 AM, the patient experienced FATIGUE (fatigue), CHILLS (chills), HEADACHE (headache) and PYREXIA (low grade fever). In February 2021, FATIGUE (fatigue), CHILLS (chills), HEADACHE (headache) and PYREXIA (low grade fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient herself took two doses of Tylenol for treating events. The events resolved within 24-hours.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Back pain, Body temperature, Chills, Confusional state
Clinical narrative: Pretty bad muscle aches; Dizziness; Really bad migraine headache; Confusion; Forgetfulness; Anxiety has been heightened, described as she has started worrying and maybe being; Chills; Fever; Nausea; Diarrhea; Neck tension/ back tension; Neck pain; Back pain; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Really bad migraine headache), CONFUSIONAL STATE (Confusion), MEMORY IMPAIRMENT (Forgetfulness), ANXIETY (Anxiety has been heightened, described as she has started worrying and maybe being) and BACK PAIN (Back pain) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 020B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history). Concomitant products included ETONOGESTREL (NEXPLANON) for an unknown indication.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Apr-2021 at 2:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Apr-2021, the patient experienced DIARRHOEA (Diarrhea) and NAUSEA (Nausea). On 12-Apr-2021 at 1:00 AM, the patient experienced CHILLS (Chills) and PYREXIA (Fever). On 13-Apr-2021, the patient experienced MIGRAINE (Really bad migraine headache), CONFUSIONAL STATE (Confusion), MEMORY IMPAIRMENT (Forgetfulness) and ANXIETY (Anxiety has been heightened, described as she has started worrying and maybe being). On 14-Apr-2021, the patient experienced DIZZINESS (Dizziness). In April 2021, the patient experienced BACK PAIN (Back pain), MUSCULOSKELETAL STIFFNESS (Neck tension/ back tension) and NECK PAIN (Neck pain). On an unknown date, the patient experienced MYALGIA (Pretty bad muscle aches). On 13-Apr-2021, CHILLS (Chills), PYREXIA (Fever) and NAUSEA (Nausea) had resolved. At the time of the report, MIGRAINE (Really bad migraine headache) and DIARRHOEA (Diarrhea) had not resolved and CONFUSIONAL STATE (Confusion), MEMORY IMPAIRMENT (Forgetfulness), ANXIETY (Anxiety has been heightened, described as she has started worrying and maybe being), BACK PAIN (Back pain), DIZZINESS (Dizziness), MUSCULOSKELETAL STIFFNESS (Neck tension/ back tension), NECK PAIN (Neck pain) and MYALGIA (Pretty bad muscle aches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Apr-2021, Body temperature: 38 degree Celsius (High) Mild fever.         Treatment information included paracetamol. Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to MOD-2021-077213 (Patient Link).
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dizziness, Memory impairment, Migraine, Musculoskeletal stiffness
Clinical narrative: Pretty bad muscle aches; Dizziness; Really bad migraine headache; Confusion; Forgetfulness; Anxiety has been heightened, described as she has started worrying and maybe being; Chills; Fever; Nausea; Diarrhea; Neck tension/ back tension; Neck pain; Back pain; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Really bad migraine headache), CONFUSIONAL STATE (Confusion), MEMORY IMPAIRMENT (Forgetfulness), ANXIETY (Anxiety has been heightened, described as she has started worrying and maybe being) and BACK PAIN (Back pain) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 020B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history). Concomitant products included ETONOGESTREL (NEXPLANON) for an unknown indication.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Apr-2021 at 2:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Apr-2021, the patient experienced DIARRHOEA (Diarrhea) and NAUSEA (Nausea). On 12-Apr-2021 at 1:00 AM, the patient experienced CHILLS (Chills) and PYREXIA (Fever). On 13-Apr-2021, the patient experienced MIGRAINE (Really bad migraine headache), CONFUSIONAL STATE (Confusion), MEMORY IMPAIRMENT (Forgetfulness) and ANXIETY (Anxiety has been heightened, described as she has started worrying and maybe being). On 14-Apr-2021, the patient experienced DIZZINESS (Dizziness). In April 2021, the patient experienced BACK PAIN (Back pain), MUSCULOSKELETAL STIFFNESS (Neck tension/ back tension) and NECK PAIN (Neck pain). On an unknown date, the patient experienced MYALGIA (Pretty bad muscle aches). On 13-Apr-2021, CHILLS (Chills), PYREXIA (Fever) and NAUSEA (Nausea) had resolved. At the time of the report, MIGRAINE (Really bad migraine headache) and DIARRHOEA (Diarrhea) had not resolved and CONFUSIONAL STATE (Confusion), MEMORY IMPAIRMENT (Forgetfulness), ANXIETY (Anxiety has been heightened, described as she has started worrying and maybe being), BACK PAIN (Back pain), DIZZINESS (Dizziness), MUSCULOSKELETAL STIFFNESS (Neck tension/ back tension), NECK PAIN (Neck pain) and MYALGIA (Pretty bad muscle aches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Apr-2021, Body temperature: 38 degree Celsius (High) Mild fever.         Treatment information included paracetamol. Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to MOD-2021-077213 (Patient Link).
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Neck pain, Pyrexia
Clinical narrative: Pretty bad muscle aches; Dizziness; Really bad migraine headache; Confusion; Forgetfulness; Anxiety has been heightened, described as she has started worrying and maybe being; Chills; Fever; Nausea; Diarrhea; Neck tension/ back tension; Neck pain; Back pain; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Really bad migraine headache), CONFUSIONAL STATE (Confusion), MEMORY IMPAIRMENT (Forgetfulness), ANXIETY (Anxiety has been heightened, described as she has started worrying and maybe being) and BACK PAIN (Back pain) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 020B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history). Concomitant products included ETONOGESTREL (NEXPLANON) for an unknown indication.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Apr-2021 at 2:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Apr-2021, the patient experienced DIARRHOEA (Diarrhea) and NAUSEA (Nausea). On 12-Apr-2021 at 1:00 AM, the patient experienced CHILLS (Chills) and PYREXIA (Fever). On 13-Apr-2021, the patient experienced MIGRAINE (Really bad migraine headache), CONFUSIONAL STATE (Confusion), MEMORY IMPAIRMENT (Forgetfulness) and ANXIETY (Anxiety has been heightened, described as she has started worrying and maybe being). On 14-Apr-2021, the patient experienced DIZZINESS (Dizziness). In April 2021, the patient experienced BACK PAIN (Back pain), MUSCULOSKELETAL STIFFNESS (Neck tension/ back tension) and NECK PAIN (Neck pain). On an unknown date, the patient experienced MYALGIA (Pretty bad muscle aches). On 13-Apr-2021, CHILLS (Chills), PYREXIA (Fever) and NAUSEA (Nausea) had resolved. At the time of the report, MIGRAINE (Really bad migraine headache) and DIARRHOEA (Diarrhea) had not resolved and CONFUSIONAL STATE (Confusion), MEMORY IMPAIRMENT (Forgetfulness), ANXIETY (Anxiety has been heightened, described as she has started worrying and maybe being), BACK PAIN (Back pain), DIZZINESS (Dizziness), MUSCULOSKELETAL STIFFNESS (Neck tension/ back tension), NECK PAIN (Neck pain) and MYALGIA (Pretty bad muscle aches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Apr-2021, Body temperature: 38 degree Celsius (High) Mild fever.         Treatment information included paracetamol. Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to MOD-2021-077213 (Patient Link).
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Limb discomfort, Pain in extremity
Clinical narrative: Mild headache; Can't raise left arm; Soreness on left arm; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Mild headache), LIMB DISCOMFORT (Can't raise left arm) and PAIN IN EXTREMITY (Soreness on left arm) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 045A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Mar-2021, the patient experienced HEADACHE (Mild headache), LIMB DISCOMFORT (Can't raise left arm) and PAIN IN EXTREMITY (Soreness on left arm). At the time of the report, HEADACHE (Mild headache), LIMB DISCOMFORT (Can't raise left arm) and PAIN IN EXTREMITY (Soreness on left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant information  provided. Treatment included Heat over the area
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: symptom of little soreness at injection arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (symptom of little soreness at injection arm) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A21A and 032B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Mar-2021, the patient experienced VACCINATION SITE PAIN (symptom of little soreness at injection arm). On 15-Mar-2021, VACCINATION SITE PAIN (symptom of little soreness at injection arm) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant product use was not provided by the reporter. Treatment included Tylenol   This case was linked to US-MODERNATX, INC.-MOD-2021-077295 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-077295:second dose case
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia, Urticaria, Vaccination site pain
Clinical narrative: 3 large red welts little raised; tender to touch and not itchy; mild fever of 100.5 F; chills; bad headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (mild fever of 100.5 F), CHILLS (chills), HEADACHE (bad headache), URTICARIA (3 large red welts little raised) and VACCINATION SITE PAIN (tender to touch and not itchy) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A21A and 032B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Apr-2021, the patient experienced PYREXIA (mild fever of 100.5 F), CHILLS (chills) and HEADACHE (bad headache). On an unknown date, the patient experienced URTICARIA (3 large red welts little raised) and VACCINATION SITE PAIN (tender to touch and not itchy). On 12-Apr-2021, PYREXIA (mild fever of 100.5 F), CHILLS (chills) and HEADACHE (bad headache) had resolved. At the time of the report, URTICARIA (3 large red welts little raised) and VACCINATION SITE PAIN (tender to touch and not itchy) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   treatment include: Tylenol were reported   This case was linked to US-MODERNATX, INC.-MOD-2021-077279 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-077279:
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Breast mass, Pruritus, Rash
Clinical narrative: two bumps on left hand side above breast plate; itching rash on right side of neck; rash around her breast plate; This spontaneous case was reported by a consumer and describes the occurrence of BREAST MASS (two bumps on left hand side above breast plate), PRURITUS (itching rash on right side of neck) and RASH (rash around her breast plate) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy (to Prozac). Concomitant products included ARIPIPRAZOLE (ABILIFY), ATORVASTATIN, LISINOPRIL, OXYCODONE and DIAZEPAM (VALIUM) for an unknown indication.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BREAST MASS (two bumps on left hand side above breast plate), PRURITUS (itching rash on right side of neck) and RASH (rash around her breast plate). At the time of the report, BREAST MASS (two bumps on left hand side above breast plate), PRURITUS (itching rash on right side of neck) and RASH (rash around her breast plate) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment included Cortisone Plus
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm soreness; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (arm soreness) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm soreness). At the time of the report, PAIN IN EXTREMITY (arm soreness) outcome was unknown. Not Provided          No Concomitant information  provided. No Treatment information  provided
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Nonspecific reaction, Product administered to patient of inappropriate age
Clinical narrative: Normal reaction with first dose; 16 year old male who received first dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old male who received first dose) and NONSPECIFIC REACTION (Normal reaction with first dose) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old male who received first dose). On an unknown date, the patient experienced NONSPECIFIC REACTION (Normal reaction with first dose). On 27-Jan-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old male who received first dose) had resolved. At the time of the report, NONSPECIFIC REACTION (Normal reaction with first dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.  The patient was 17 year old and discussed with moderna person, the patient was scheduled for second dose.   Most recent FOLLOW-UP information incorporated above includes: On 14-Apr-2021: Adverse event, normal reaction with the first shot updated. On 14-Apr-2021: Second dose information with events updated. On 14-Apr-2021: MOD21-077328 email added (narrative updated)
Sex: F
Vaccine: COVID19
Symptoms: Chills, Illness, Pain in extremity, Pyrexia, Vomiting
Clinical narrative: chills; Felt very sick; Fever; Vomited; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), CHILLS (chills), ILLNESS (Felt very sick), PYREXIA (Fever) and VOMITING (Vomited) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In February 2021, the patient experienced PAIN IN EXTREMITY (Sore arm). In March 2021, the patient experienced CHILLS (chills), ILLNESS (Felt very sick), PYREXIA (Fever) and VOMITING (Vomited). At the time of the report, PAIN IN EXTREMITY (Sore arm), CHILLS (chills), ILLNESS (Felt very sick), PYREXIA (Fever) and VOMITING (Vomited) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant information  provided. No Treatment information  provided
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Confusional state, Dizziness, Dyspnoea
Clinical narrative: difficulty breathing; swelling of face; throat swelling; dizziness; confusion; nausea; chills; muscle pain; joint pain; headache; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (difficulty breathing), SWELLING FACE (swelling of face), PHARYNGEAL SWELLING (throat swelling), DIZZINESS (dizziness) and CONFUSIONAL STATE (confusion) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (difficulty breathing), SWELLING FACE (swelling of face), PHARYNGEAL SWELLING (throat swelling), DIZZINESS (dizziness), CONFUSIONAL STATE (confusion), NAUSEA (nausea), CHILLS (chills), MYALGIA (muscle pain), ARTHRALGIA (joint pain), HEADACHE (headache) and FATIGUE (fatigue). At the time of the report, DYSPNOEA (difficulty breathing), SWELLING FACE (swelling of face), PHARYNGEAL SWELLING (throat swelling), DIZZINESS (dizziness), CONFUSIONAL STATE (confusion), NAUSEA (nausea), CHILLS (chills), MYALGIA (muscle pain), ARTHRALGIA (joint pain), HEADACHE (headache) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication use was not reported.   Treatment information was not reported.   This case was linked to MOD-2021-076391 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Nausea, Pharyngeal swelling
Clinical narrative: difficulty breathing; swelling of face; throat swelling; dizziness; confusion; nausea; chills; muscle pain; joint pain; headache; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (difficulty breathing), SWELLING FACE (swelling of face), PHARYNGEAL SWELLING (throat swelling), DIZZINESS (dizziness) and CONFUSIONAL STATE (confusion) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (difficulty breathing), SWELLING FACE (swelling of face), PHARYNGEAL SWELLING (throat swelling), DIZZINESS (dizziness), CONFUSIONAL STATE (confusion), NAUSEA (nausea), CHILLS (chills), MYALGIA (muscle pain), ARTHRALGIA (joint pain), HEADACHE (headache) and FATIGUE (fatigue). At the time of the report, DYSPNOEA (difficulty breathing), SWELLING FACE (swelling of face), PHARYNGEAL SWELLING (throat swelling), DIZZINESS (dizziness), CONFUSIONAL STATE (confusion), NAUSEA (nausea), CHILLS (chills), MYALGIA (muscle pain), ARTHRALGIA (joint pain), HEADACHE (headache) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication use was not reported.   Treatment information was not reported.   This case was linked to MOD-2021-076391 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Swelling face
Clinical narrative: difficulty breathing; swelling of face; throat swelling; dizziness; confusion; nausea; chills; muscle pain; joint pain; headache; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (difficulty breathing), SWELLING FACE (swelling of face), PHARYNGEAL SWELLING (throat swelling), DIZZINESS (dizziness) and CONFUSIONAL STATE (confusion) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (difficulty breathing), SWELLING FACE (swelling of face), PHARYNGEAL SWELLING (throat swelling), DIZZINESS (dizziness), CONFUSIONAL STATE (confusion), NAUSEA (nausea), CHILLS (chills), MYALGIA (muscle pain), ARTHRALGIA (joint pain), HEADACHE (headache) and FATIGUE (fatigue). At the time of the report, DYSPNOEA (difficulty breathing), SWELLING FACE (swelling of face), PHARYNGEAL SWELLING (throat swelling), DIZZINESS (dizziness), CONFUSIONAL STATE (confusion), NAUSEA (nausea), CHILLS (chills), MYALGIA (muscle pain), ARTHRALGIA (joint pain), HEADACHE (headache) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication use was not reported.   Treatment information was not reported.   This case was linked to MOD-2021-076391 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: the sickest; This spontaneous case was reported by a patient and describes the occurrence of ILLNESS (the sickest) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 13-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 14-Apr-2021, the patient experienced ILLNESS (the sickest). At the time of the report, ILLNESS (the sickest) had not resolved.            Concomitant product use was not provided. Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia, Vomiting
Clinical narrative: Vomited; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (Vomited), PYREXIA (Fever) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VOMITING (Vomited), PYREXIA (Fever) and CHILLS (Chills). At the time of the report, VOMITING (Vomited), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant information  provided. No Treatment information  provided.   This case was linked to MOD-2021-077325 (E2B Linked Report).; Sender's Comments:  MOD-2021-077325:First dose case
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling abnormal, Pyrexia, Swelling
Clinical narrative: red; swollen; feel like its drawing; feel like having fever in that spot; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (red), SWELLING (swollen), FEELING ABNORMAL (feel like its drawing) and PYREXIA (feel like having fever in that spot) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (red), SWELLING (swollen), FEELING ABNORMAL (feel like its drawing) and PYREXIA (feel like having fever in that spot). At the time of the report, ERYTHEMA (red), SWELLING (swollen), FEELING ABNORMAL (feel like its drawing) and PYREXIA (feel like having fever in that spot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant information  provided. No Treatment information  provided
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: experienced tiredness for one half of the day; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (experienced tiredness for one half of the day) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M2UA) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced FATIGUE (experienced tiredness for one half of the day). At the time of the report, FATIGUE (experienced tiredness for one half of the day) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information was provided. No treatment medication information was provided.